Pelthos Therapeutics appoints John M. Gay as CFO, replaces Francis Knuettel II

Pelthos Therapeutics Inc.

John M. Gay appointed CFO effective April 10, 2026; also named treasurer and secretary.
Gay previously served as SVP, Finance & Accounting since July 2025; prior CFO at LNHC and Novan.
Francis Knuettel II terminated as CFO effective April 10, 2026; no disagreement cited.
Gay's employment agreement: $425,000 base salary, 40% target annual bonus.
Press release issued April 10, 2026; CEO Scott Plesha cites strong commercial momentum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.